33,9 miljoner från Cancerfonden till forskare på Labmed

I Cancerfondens senaste utlysning gick 33,9 miljoner kronor till tolv forskare vid institutionen för laboratoriemedicin för åren 2027-2029.
Mikael Björnstedt, Professor
Titel: "Integrated Precision Stratification and Selenium-mediated Targeted Redox Therapy in Resistant Tumors with Special Emphasis on HPB cancers"
Projektanslag, totalsumma: 3 750 000 kr
Jonas Fuxe, Professor
Titel: "Cancer cell plasticity as a driver of immune evasion and lymphatic metastasis"
Projektanslag, totalsumma: 3 750 000 kr
Yizhou Hu, Researcher
Titel: "Defining and targeting the stromal lipid niche in high-risk neuroblastoma through spatial MultiOmics"
Projektanslag, totalsumma: 3 000 000 kr
Andri Lemarquis, Assistant Professor
Titel: "The role of recent thymic emigrants in tumor control"
Projektanslag, totalsumma: 3 000 000 kr
Magdalini Lourda, Docent
Titel: "LUMEN: Liquid biopsy and organoid modelling to understand and predict neurodegeneration in Langerhans cell histiocytosis"
Projektanslag, totalsumma: 3 000 000 kr
Helen Kaipe, Docent
Titel: "Combining tumorreactive T cells and CAF targeting to improve immunotherapy in pancreatic cancer"
Projektanslag, totalsumma: 3 000 000 kr
Anders Mutvei, Docent
Titel: "Lysosome abundance and organization in cancer"
Projektanslag, totalsumma: 3 000 000 kr
Dhifaf Sarhan, Docent
Titel: "Programming adaptive NK cell memory for treatment durability and relapse prevention in high-grade serous ovarian cancer"
Projektanslag, totalsumma: 3 000 000 kr
Matti Sällberg, Professor
Titel: "Genetic vaccines and immune-based therapies to prevent severe liver disease and cancer caused by chronic viral hepatitis: Therapy development and models"
Projektanslag, totalsumma: 3 000 000 kr
Oscar Wiklander, Assistant Professor
Titel: "Extracellular Vesicles as an Integrated Platform for Precision-Guided Cancer Therapy"
Projektanslag, totalsumma: 3 000 000 kr
Peter Bergman, Professor
Titel: "Can a new drug reduce intestinal damage during chemotherapy treatment by activating the natural immunity in the intestinal mucosa?"
Projektanslag, totalsumma: 1 600 000 kr
Stephan Mielke, Professor
Titel: "Early risk stratification in CAR T-cell therapy to improve safety, access and outcome"
Projektanslag, totalsumma: 800 000 kr